ISEE - IVERIC bio Inc
Close
39.95
39.950 100.000%
Share volume: 0
Last Updated: Mon 10 Jul 2023 08:08:42 PM CEST
Pharmaceutical Preparation Manufacturing :
2.70%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
38%
Profitability
45%
Dept financing
5%
Liquidity
50%
Performance
37%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.73%
Return on assets
-5.22%
Return on sales
0%
Return on invested capital
-14.68%
Total debt ratio
59.54%
Debt ratio change over timeo
-0.58%
Current Ratio
11.7%
Quick Ratio
0%
Cash Position Ratio
10.28%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.25%
Return on assets
-12.09%
Return on sales
0%
Return on invested capital
146.56%
Total debt ratio
8.21%
Debt ratio change over timeo
-0.95%
Current Ratio
13.32%
Quick Ratio
0%
Cash Position Ratio
11.63%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.86%
Return on assets
-10.86%
Return on sales
0%
Return on invested capital
128.95%
Total debt ratio
8.53%
Debt ratio change over time
-0.95%
Current Ratio
11.76%
Quick Ratio
0%
Cash Position Ratio
6.16%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-76.05%
Return on assets
-99.85%
Return on sales
0%
Return on invested capital
-154.6%
Total debt ratio
-57.56%
Debt ratio change over time
-0.58%
Current Ratio
5.53%
Quick Ratio
0%
Cash Position Ratio
4.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ISEE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 7.73% | 0% | 0% | 26.83% |
| Return on assets | -5.22% | 0% | 0% | -10.24% |
| Return on sales | 0% | 0% | 0% | -1670.47% |
| Return on invested capital | -14.68% | 0% | 0% | 57.71% |
| Profitability | 32% | 0% | 25% | 50% |
| Total debt ratio | 59.54% | 0% | 0% | 168.24% |
| Debt ratio change over time | -0.58% | 0% | 0% | 17.84% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 13.32% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 11.63% | 0% | 0% | 7.97% |
| Liquididy | 50% | 0% | 0% | 46% |
| Short-term ratios | ISEE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -12.25% | 0% | 0% | -39.65% |
| Return on assets | -12.09% | 0% | 0% | -13.45% |
| Return on sales | 0% | 0% | 0% | -4352.39% |
| Return on invested capital | 146.56% | 0% | 0% | 120.66% |
| Profitability | 50% | 0% | 50% | 21% |
| Total debt ratio | 8.21% | 0% | 0% | 65.53% |
| Debt ratio change over time | -0.95% | 0% | 0% | 0.08% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 13.32% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 11.63% | 0% | 0% | 7.97% |
| Liquididy | 50% | 0% | 0% | 58% |